Web notes  

February 2021
FUNDING OPPORTUNITIES- Back

COVID-19 Funding Opportunities

The Office of the Vice Provost for Research (VPR) has compiled a list of funding opportunities specific to COVID-19. This list will be updated as new opportunities arise.


COVID-19 Grants for JHU Faculty

Submission deadline: Monday, February 22, 2021

The Johns Hopkins University School of Medicine, through a gift from the Bentivoglio Family Foundation, is offering two COVID-19 related grants for JHU faculty. Solicitation, review and awarding of grants is managed by staff of the Division of Infectious Diseases, led by Paul Auwaerter, MD and Mark Sulkowski, MD.

COVID-19 Vaccine-related Research Fund (C19VRF)

  • Provides funds for clinical or translational research to optimize community vaccine uptake and understand vaccine safety and effectiveness in persons underrepresented in the initial clinical trials of SARS-CoV-2 vaccines, such as persons of under-represented minority, ethnic, or social groups, pregnant women, persons with prior severe allergic reactions, immunosuppressed patients, and children.
  • Provides funds for clinical or translational research of survivors of COVID-19 for whom the risks and benefits of SARS-CoV-2 vaccines are incompletely understood, particularly in those individuals with ongoing signs and symptoms.
  • Provides funds for clinical or translational research to understand the virologic and immunologic correlations of protection from disease, prevention of transmission and vaccine response duration with different SARS-CoV-2 vaccines (e.g., mRNA, adenoviruses platforms, and others)

Post-acute COVID-19 Syndrome Discovery Fund (PAC19SDF)
Provides funds for clinical or translational research focused on understanding the incidence and long-term prognosis of late sequelae in persons with mild, moderate, and severe COVID-19 disease, identify the underlying pathology, and develop evidence-based treatments.

Questions? Contact Yvonne Higgins (yhiggins@jhmi.edu or 410-302-4753)


Michael J. Fox Foundation (MJFF) Challenge

No application deadline

The Michael J. Fox Foundation is sponsoring a $2 million prize to the first team to develop a viable selective alpha-synuclein PET tracer and agree to make that tracer available broadly.

The ability to image alpha-synuclein deposition in the brain would be a game-changing achievement for the Parkinson's disease (PD) field. The accumulation of aggregated alpha-synuclein is a pathological hallmark of PD and a priority target for drug development given its hypothesized contribution to neurodegeneration. In vivo imaging of alpha-synuclein pathology could be useful as a biomarker of the presence of disease and disease progression and as a pharmacodynamic tool for drug development. With this prize, the Foundation seeks to attract research teams and accelerate momentum to speed the development of such a tracer.

Contestants: Anyone is eligible for the prize who agrees to all contest rules. Contestants may be MJFF funded or not and can be from either academia or industry.

Contest rules:

  1. Contestants must apply for the prize with pre-clinical and clinical data supporting the broad use of their alpha-synuclein radiotracer. Judges may ask for additional data, including but not limited to raw imaging data.
  2. NOTE: All contestants must agree to make the winning radiotracer available for use by The Michael J. Fox Foundation and MJFF awardees through a nonexclusive license or other MJFF-approved mechanism.

Criteria for winning: The winning contestant must demonstrate that the radiotracer binds with relatively high selectivity to alpha-synuclein according to pre-specified criteria and must demonstrate proof-of-concept in human subjects, including people with Parkinson's disease and/or another synucleinopathy. See below for more details on submission requirements.

Timeline: There is no deadline for submissions. The $2 million award will be issued to the first contestant who submits compelling evidence of a viable selective tracer and agrees to its widespread use. If no award is given by mid-2018, The Michael J. Fox Foundation will evaluate the state of the field and utility of such a prize.


Return to top of Funding Opportunities

 
   
February 2021 articles:
Essential Information for Human Subjects Research Teams Related to COVID-19
Third Thursdays with the ICTR Lecture Series - Biomarker Development Metabolomics Unit, February
Coronavirus Research Billing Notices and FAQ
Managing Investigational Product Returns from Research Participants
Update to Organization Policy on Registration of Clinical Trials
Changes in HSR Recertification
Update on Insurance and Research Participant Financial Responsibility Information Sheet: Signature No Longer Required
Change in JHM IRB Review Fees for Commercially-Funded Studies
Data and Safety Monitoring Board Training Manual Now Available
Good Clinical Practice (GCP) Fundamentals: Understanding and Applying GCP to Human Subject Research
Fee Schedule Adjustment for Hospital Services Charged to Clinical Trial Budgets
Changes to NIH-funded Human Subjects Research
Free Resources for Longitudinal Clinical Research Studies
JHM IRB Reliance Requests
Sharing Partnership for Innovative Research in Translation
Johns Hopkins Institute for Clinical and Translational Research
Johns Hopkins Clinical Research Network
 
Visit Animal Care and Use Committee Website
Current Classes
"Interinstitutional Assurance" Agreement
Health, Safety, and Environment (HSE) presents: Safety in Research Updates
COVID-19 Funding Opportunities
COVID-19 Grants for JHU Faculty
Michael J. Fox Foundation (MJFF) Challenge
Updated Guidance from NIH on COVID-19 Flexibilities for Applicants and Recipients
COVID-19 and Research Updates
New System to Request Outgoing Subawards
Point of Contact for NIH Loan Repayment Program
JHU SOM Update on NIH Policy on Foreign Involvement
Disclosure of Payments from Foreign Educational Institutions and Government Agencies
Institutional Letter of Support Required for Institutional Training Grant Applications
Notice to the Johns Hopkins Community Regarding the National Science Foundation Grant Reporting Requirement for Harassment Findings and Actions
Prohibited Mention of Prior Review for New Replacement Applications
NIH Policy on Foreign Component Involvement
NIH Policy: Foreign Components Added to a Grant to a Domestic or Foreign Organization
Why Project Outcomes Matter in your Interim and Final Research Performance Progress Report (RPPR)
NIH Matchmaker, A Tool For Finding Similar NIH Projects
NIH Video Tutorials on How to Apply for Grants

This Month's Departmental Listings

Upcoming Deadlines for February, March and April

Updates and February Events at the Genetics Research Core Facilities
       

 

JHM AppointmentsEmployment @ JHM | Finding a Doctor | Disclaimer | Maps & Directions | Contact JHM 

 

                                                                                                                                                           The Web Center